CIK 0001746466
- Non-accelerated filer
- Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821554746
- Phone
- +1 858-412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.65 ($6,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.70 ($7,000)
- 4 Planned sale Sr. Vice President and COO sold 15,000 shares at $1.25 ($18,750)
- 4 Planned sale Principal Accounting Officer sold 3,518 shares at $1.25 ($4,398)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.81 ($8,100)
- 4 Planned sale Principal Accounting Officer sold 38,806 shares at $0.85 ($32,985)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.87 ($8,700)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 9 · 177 filings